Overcoming COVID-19 in West African countries: is herd immunity an option?

被引:0
|
作者
Ilesanmi, Olayinka Stephen [1 ,2 ]
Akande, Abayomi [2 ]
Afolabi, Aanuoluwapo Adeyimika [1 ]
机构
[1] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Oyo State, Nigeria
[2] Univ Coll Hosp, Dept Community Med, Ibadan, Oyo State, Nigeria
关键词
COVID-19; herd immunity; vaccine; case fatality rate; deaths;
D O I
10.11604/pamj.supp.2020.35.103.24217
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The coronavirus infection (COVID-19) to date has no vaccine or effective treatment. Herd immunity offers indirect protection to susceptible members of the population. If the acquired immunity of a community rises above 67%, then a gradual decline in the number of incident cases is recorded. How many deaths would have occurred in the West African countries by the time at least 67% of our people are infected with the present case fatality rate (CFR)? The objective of this study was to develop a forecast of the number of COVID-19 deaths that would be recorded to attain herd immunity for each country in West-Africa. We predicted the numbers of deaths using publicly available demographic and COVID-19 data. To attain herd immunity in West Africa 5.2 million COVID-19 deaths would have occurred assuming the CFR is maintained at the current rates in the region. Attention should be focused on strategies that would limit the spread of infection and protect the most vulnerable population groups while the race to develop an effective vaccine should be hastened.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [41] Radicalizing moral conservatism in herd immunity during COVID-19
    Kahambing, Jan Gresil
    [J]. JOURNAL OF PUBLIC HEALTH, 2022, 44 (04) : E606 - E607
  • [42] COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
    Khalife, Jade
    VanGennep, Derrick
    [J]. EPIDEMIOLOGY AND HEALTH, 2021, 43
  • [43] Caveats on COVID-19 herd immunity threshold: the Spain case
    Garcia-Garcia, David
    Morales, Enrique
    Fonfria, Eva S.
    Vigo, Isabel
    Bordehore, Cesar
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] COVID-19: Herd immunity and convalescent plasma transfer therapy
    Syal, Kirtimaan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1380 - 1382
  • [45] Can herd immunity be relied on as a strategy to combat COVID-19?
    Virk, Amrit
    Samdarshi, Narottam
    [J]. INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2020, 9 : 73 - 76
  • [46] Can India develop herd immunity against COVID-19?
    A. Gowrisankar
    Lamberto Rondoni
    Santo Banerjee
    [J]. The European Physical Journal Plus, 135
  • [47] Herd immunity in COVID-19: Needs de-emphasizing
    Raina, Sunil Kumar
    Kumar, Raman
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (05) : 1595 - 1597
  • [48] Can COVID-19 herd immunity be achieved at a city level?
    Arbel, Yuval
    Arbel, Yifat
    Kerner, Amichai
    Kerner, Miryam
    [J]. PLOS ONE, 2024, 19 (05):
  • [49] Caveats on COVID-19 herd immunity threshold: the Spain case
    David García-García
    Enrique Morales
    Eva S. Fonfría
    Isabel Vigo
    Cesar Bordehore
    [J]. Scientific Reports, 12
  • [50] The Concept of Classical Herd Immunity May Not Apply to COVID-19
    Morens, David M.
    Folkers, Gregory K.
    Fauci, Anthony S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (02): : 195 - 198